Paper-Based Immunoassay with Signal Amplification for Sensitive Detection of Nucleocapsid Protein Toward the Diagnosis of Long COVID

Abstract

Long COVID is characterized by persistent symptoms, including fatigue, cognitive impairment, and respiratory issues, affecting a considerable number of individuals post-infection. The underlying mechanism is not fully understood, but it has been proposed to involve the reactivation of virus, which subsequently induces immune dysregulation. In this proof-of-concept study, we developed a paper-based immunoassay for the detection of the nucleocapsid (N) protein, which due to its stability and low mutation rate, is a valuable biomarker for detecting residual viral presence. By utilizing reporter antibodies conjugated to cleavable ionic probes through dendrimer chemistry, we were able to analyze the immunoassay results with ambient mass spectrometry using on-chip paper spray ionization. The used dendrimer enhanced mass spectrometry sensitivity by enabling the attachment of multiple ionic probes to a single reporter antibody. The method presented here achieved a limit of detection of 2.4 pM for N protein detection from paper. Unlike traditional sensitive COVID tests that are only accessible to hospitalized individuals, our paper-based assay has potential to enable long COVID to be detected under resource-limited settings. Our method was applied to analyze 20 human plasma samples, including 10 from individuals with long COVID and 10 from healthy controls with no history of SARS-CoV-2 infection. We observed a significantly higher MS signal—up to two orders of magnitude—for samples collected from long COVID patients compared to controls. The ability to use the paper device in remote locations tested by evaluating the stability of the assay, which showed that after 30 days of storage at room temperature, the device retained sufficient analytical performance. Given this robustness, we believe our platform will be suitable for direct-to-consumer testing, enabling individuals with low viral loads to be screened in a timely fashion.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
01 Dec 2025
Accepted
12 Feb 2026
First published
16 Feb 2026
This article is Open Access
Creative Commons BY-NC license

Analyst, 2026, Accepted Manuscript

Paper-Based Immunoassay with Signal Amplification for Sensitive Detection of Nucleocapsid Protein Toward the Diagnosis of Long COVID

M. Duarte da Silva, R. Speidel, A. Seth, H. J.C. de Carvalho, M. Miglino and A. K. Badu-Tawiah, Analyst, 2026, Accepted Manuscript , DOI: 10.1039/D5AN01267H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements